BiondVax signs exclusive license agreement for development and commercialization of a novel anti-IL-17 antibody for treatment of autoimmune and inflammatory diseases including psoriasis
05 juin 2023 07h00 HE
|
BiondVax Pharmaceuticals Ltd.
Broad-based collaboration with Max Planck and University Medical Center Gottingen yields attractive anti-IL-17 VHH antibodies (NanoAbs); includes exclusive worldwide license for all potential...
Key Digital Marketing Metrics of Pharma Assets in Psoriasis, 2023: Branded Websites for Patients and HCPs, Unbranded Websites, and Social Media Accounts
01 juin 2023 10h08 HE
|
Research and Markets
Dublin, June 01, 2023 (GLOBE NEWSWIRE) -- The "Digital Marketing Trends in Psoriasis" report has been added to ResearchAndMarkets.com's offering. This report assesses key digital marketing...
STRATA Skin Sciences Announces TheraClear®X Product Demonstration at Music City Scale Symposium for Cosmetic Advances and Laser Education
19 mai 2023 08h00 HE
|
STRATA Skin Sciences, Inc.
HORSHAM, Pa., May 19, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for...
Chemical Peel Global Market to 2030: Increasing Awareness Among the Masses About Their Skin Drives Growth
19 mai 2023 07h43 HE
|
Research and Markets
Dublin, May 19, 2023 (GLOBE NEWSWIRE) -- The "Chemical Peel Market Size, Share & Trends Analysis Report By Type (Medium Peel), By Application (Acne Spots, Wrinkles), By Product (Fruit Peel) By...
STRATA Skin Sciences Reports First Quarter 2023 Revenue
15 mai 2023 16h01 HE
|
STRATA Skin Sciences, Inc.
Achieved revenue of $7.6 million for the first quarter 2023 Company to host conference call and webcast today, May 15, 2023, at 4:30 PM ET HORSHAM, Pa., May 15, 2023 (GLOBE NEWSWIRE) -- STRATA...
STRATA Skin Sciences Enters India Market with Exclusive Distribution Agreement with Spectra Medical
15 mai 2023 08h00 HE
|
STRATA Skin Sciences, Inc.
STRATA expects to receive regulatory approval in India during December 2023 India has the highest prevalence of vitiligo in the world, at about 8.8%1 HORSHAM, Pa., May 15, 2023 (GLOBE NEWSWIRE) --...
Novan Reports First Quarter 2023 Financial Results and Provides Corporate Update
15 mai 2023 06h45 HE
|
Novan, Inc.
– Continued progress toward PDUFA goal date of January 5, 2024, for berdazimer gel, 10.3% (SB206) – – Strong prescription growth across three promoted products – – Company to host conference call...
Mindera Health™ Announces Change to Executive Leadership Team
11 mai 2023 15h57 HE
|
Mindera Health
San Diego, CA, May 11, 2023 (GLOBE NEWSWIRE) -- Mindera Health™, the developer of Mind.Px™, the first realization of precision medicine in psoriasis, has announced a change in its executive...
STRATA Skin Sciences to Participate in Inaugural EF Hutton Global Conference
08 mai 2023 08h00 HE
|
STRATA Skin Sciences, Inc.
HORSHAM, Pa., May 08, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for...
STRATA Skin Sciences to Report First Quarter 2023 Financial Results on May 15, 2023
02 mai 2023 08h00 HE
|
STRATA Skin Sciences, Inc.
HORSHAM, Pa., May 02, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for...